Attralus, Inc.

Scion Life Sciences, an affiliate of the health care investment firm Petrichor, launched on 7 February with two friends and former Apple Tree Partners (ATP) colleagues – Scion co-founders and managing

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. BMS Exits 2015 Gene Therapy Partnership

Attralus, Inc. has raised a $116m series B financing that it says will bring the first of its pan-amyloid removal (PAR) drug candidates into the clinic and advance development of a diagnostic for det

Neogene Therapeutics, Inc. , with a $110m series A venture capital round, led a group of five biopharmaceutical companies that revealed $320m in significant VC financings on a single day. The New York